These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 9682833
1. [Phe1psi(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord. Xu IS, Wiesenfeld-Hallin Z, Xu XJ. Neurosci Lett; 1998 Jun 19; 249(2-3):127-30. PubMed ID: 9682833 [Abstract] [Full Text] [Related]
3. Supraspinal and spinal effects of [Phe1psi(CH2-NH)Gly2]-nociceptin(1-13)-NH2 on nociception in the rat. Candeletti S, Guerrini R, Calò G, Romualdi P, Ferri S. Life Sci; 2000 Jun 19; 66(3):257-64. PubMed ID: 10666001 [Abstract] [Full Text] [Related]
10. Intrathecal [Nphe1]nociceptin( 1-13)NH2 selectively reduces the spinal inhibitory effect of nociceptin. Xu IS, Grass S, Calo G, Guerrini R, Wiesenfeld-Hallin Z, Xu XJ. Life Sci; 2002 Jan 25; 70(10):1151-7. PubMed ID: 11848299 [Abstract] [Full Text] [Related]
11. [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray. Chiou LC. Br J Pharmacol; 1999 Sep 25; 128(1):103-7. PubMed ID: 10498840 [Abstract] [Full Text] [Related]
12. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor. Guerrini R, Caló G, Bigoni R, Rizzi A, Varani K, Toth G, Gessi S, Hashiba E, Hashimoto Y, Lambert DG, Borea PA, Tomatis R, Salvadori S, Regoli D. J Med Chem; 2000 Jul 27; 43(15):2805-13. PubMed ID: 10956188 [Abstract] [Full Text] [Related]
13. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors. Okawa H, Nicol B, Bigoni R, Hirst RA, Calo G, Guerrini R, Rowbotham DJ, Smart D, McKnight AT, Lambert DG. Br J Pharmacol; 1999 May 27; 127(1):123-30. PubMed ID: 10369464 [Abstract] [Full Text] [Related]
14. A new selective antagonist of the nociceptin receptor. Guerrini R, Calo G, Rizzi A, Bigoni R, Bianchi C, Salvadori S, Regoli D. Br J Pharmacol; 1998 Jan 27; 123(2):163-5. PubMed ID: 9489602 [Abstract] [Full Text] [Related]
15. Nociceptin and the ORL-1 ligand [Phe1psi (CH2-NH)Gly2]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain. Bertorelli R, Corradini L, Rafiq K, Tupper J, Calò G, Ongini E. Br J Pharmacol; 1999 Nov 27; 128(6):1252-8. PubMed ID: 10578139 [Abstract] [Full Text] [Related]
16. Blockade effects of (Nphe1)Nociceptin(1-13)-NH(2) on anti-nociception induced by intrathecal administration of nociceptin in rats. Lu JT, Huang YH, Palmer PP, Xie GX, Gabriel A, Grond S, Yu LC. Regul Pept; 2001 Sep 15; 101(1-3):81-5. PubMed ID: 11495682 [Abstract] [Full Text] [Related]
17. Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor. Hashimoto Y, Caló G, Guerrini R, Smith G, Lambert DG. Neurosci Lett; 2000 Jan 07; 278(1-2):109-12. PubMed ID: 10643813 [Abstract] [Full Text] [Related]
18. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa. Miller-Pérez C, Sánchez-Islas E, Pellicer F, Rodríguez-Manzo G, Cruz SL, León-Olea M. Eur J Pharmacol; 2008 Feb 26; 581(1-2):77-85. PubMed ID: 18096155 [Abstract] [Full Text] [Related]